Oxford Nanopore Technologies (ONT) Competitors GBX 139.89 -1.01 (-0.72%) (As of 11/15/2024 12:32 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades ONT vs. BTG, ABC, GNS, ERGO, SLN, OXB, PRTC, HZD, VRP, and BVXPShould you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), and Bioventix (BVXP). These companies are all part of the "biotechnology" industry. Oxford Nanopore Technologies vs. BTG Abcam Genus Ergomed Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Bioventix BTG (LON:BTG) and Oxford Nanopore Technologies (LON:ONT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations. Do analysts rate BTG or ONT? Oxford Nanopore Technologies has a consensus target price of GBX 235.50, indicating a potential upside of 68.35%. Given Oxford Nanopore Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Oxford Nanopore Technologies is more favorable than BTG.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BTG 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Oxford Nanopore Technologies 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in BTG or ONT? 38.4% of Oxford Nanopore Technologies shares are held by institutional investors. 32.6% of Oxford Nanopore Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media refer more to BTG or ONT? In the previous week, BTG had 2 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 5 mentions for BTG and 3 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of 1.14 beat BTG's score of 0.01 indicating that Oxford Nanopore Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BTG 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Oxford Nanopore Technologies 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is BTG or ONT more profitable? BTG has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. BTG's return on equity of 0.00% beat Oxford Nanopore Technologies' return on equity.Company Net Margins Return on Equity Return on Assets BTGN/A N/A N/A Oxford Nanopore Technologies -94.82%-26.08%-14.42% Which has better earnings and valuation, BTG or ONT? BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBTG£914.10M3.57N/A£28.5029.47Oxford Nanopore Technologies£167.75M7.85-£159.06M-£0.20-699.44 Does the MarketBeat Community favor BTG or ONT? BTG received 587 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 73.95% of users gave BTG an outperform vote. CompanyUnderperformOutperformBTGOutperform Votes61973.95% Underperform Votes21826.05% Oxford Nanopore TechnologiesOutperform Votes32100.00% Underperform VotesNo Votes SummaryBTG and Oxford Nanopore Technologies tied by winning 8 of the 16 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Oxford Nanopore Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONT vs. The Competition Export to ExcelMetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.32B£150.91M£5.15B£1.65BDividend YieldN/A3.64%5.18%6.87%P/E Ratio-699.44187.6766.671,777.52Price / Sales7.8516,673.191,276.84252,130.22Price / Cash4.0412.4639.7027.60Price / Book2.127.886.472.84Net Income-£159.06M-£20.05M£119.73M£158.93M7 Day Performance4.39%7.83%-5.13%-0.63%1 Month Performance-2.52%11.90%-2.71%3.39%1 Year Performance-29.78%31.41%31.08%126.08% Oxford Nanopore Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONTOxford Nanopore Technologies2.7058 of 5 starsGBX 139.89-0.7%GBX 235.50+68.3%-29.6%£1.32B£167.75M-699.441,281News CoveragePositive NewsHigh Trading VolumeBTGBTGN/AGBX 840+0.1%N/A+0.0%£3.26B£914.10M29.474,690ABCAbcamN/AGBX 1,226+11.2%N/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus1.8081 of 5 starsGBX 1,752-2.7%N/A-22.0%£1.15B£668.80M14,600.00480Gap UpERGOErgomedN/AGBX 1,346flatN/A+0.0%£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100News CoverageHigh Trading VolumeOXBOxford Biomedica0.6038 of 5 starsGBX 410.50-0.5%N/A+110.0%£432.50M£97.28M-285.07891Gap DownPRTCPureTech HealthN/AGBX 174+0.2%N/A-2.7%£416.59M£3.33M-756.52300HZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/A+0.0%£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AGBX 55+5.8%N/A+0.0%£228MN/A-1.6822Gap UpBVXPBioventixN/AGBX 3,940+0.4%N/A+3.4%£205.67M£13.60M2,417.1812News Coverage Related Companies and Tools Related Companies BTG Alternatives Abcam Alternatives Genus Alternatives Ergomed Alternatives Silence Therapeutics Alternatives Oxford Biomedica Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Bioventix Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:ONT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Nanopore Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.